To aid prognostication in breast cancer, several tumor characteristics including histologic grade, tumor size, lymph nodal involvement, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and KI67, a marker of proliferation, have been combined into clinically useful prognostic algorithms [13–16]. This evidence concerns the gene MKI67 and breast carcinoma.